Cell-cell adhesion mediated by CD8 and MHC class I molecules - PubMed (original) (raw)
. 1988 Nov 3;336(6194):79-81.
doi: 10.1038/336079a0.
Affiliations
- PMID: 3263576
- DOI: 10.1038/336079a0
Cell-cell adhesion mediated by CD8 and MHC class I molecules
A M Norment et al. Nature. 1988.
Abstract
CD4 and CD8 are cell-surface glycoproteins expressed on mutually exclusive subsets of peripheral T cells. T cells that express CD4 have T-cell antigen receptors that are specific for antigens presented by major histocompatibility complex class II molecules, whereas T cells that express CD8 have receptors specific for antigens presented by MHC class I molecules (reviewed in ref. 1). Based on this correlation and on the observation that anti-CD4 and anti-CD8 antibodies inhibit T-cell function, it has been suggested that CD4 and CD8 increase the avidity of T cells for their targets by binding to MHC class II or MHC class I molecules respectively. Also, CD4 and CD8 may become physically associated with the T-cell antigen receptor, forming a higher-affinity complex for antigen and MHC molecules, and could be involved in signal transduction. Cell-cell adhesion dependent CD4 and MHC II molecules has recently been demonstrated. To determine whether CD8 can interact with MHC class I molecules in the absence of the T-cell antigen receptor, we have developed a cell-cell binding assay that measures adhesion of human B-cell lines expressing MHC class I molecules to transfected cells expressing high levels of human CD8. In this system, CD8 and class I molecules mediate cell-cell adhesion, showing that CD8 directly binds to MHC class I molecules.
Similar articles
- Interaction between CD4 and class II MHC molecules mediates cell adhesion.
Doyle C, Strominger JL. Doyle C, et al. Nature. 1987 Nov 19-25;330(6145):256-9. doi: 10.1038/330256a0. Nature. 1987. PMID: 2823150 - Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D, Maddon P, Sekaly R, Talle MA, Godfrey M, Long E, Goldstein G, Chess L, Axel R, Kappler J, et al. Gay D, et al. Nature. 1987 Aug 13-19;328(6131):626-9. doi: 10.1038/328626a0. Nature. 1987. PMID: 3112582 - MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.
König R, Huang LY, Germain RN. König R, et al. Nature. 1992 Apr 30;356(6372):796-8. doi: 10.1038/356796a0. Nature. 1992. PMID: 1574118 - CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex.
Fleury SG, Croteau G, Sékaly RP. Fleury SG, et al. Semin Immunol. 1991 May;3(3):177-85. Semin Immunol. 1991. PMID: 1909595 Review. - [MHC tetramers: tracking specific immunity].
Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D. Kosor E, et al. Acta Med Croatica. 2003;57(4):255-9. Acta Med Croatica. 2003. PMID: 14639858 Review. Croatian.
Cited by
- Structure, function, and immunomodulation of the CD8 co-receptor.
Srinivasan S, Zhu C, McShan AC. Srinivasan S, et al. Front Immunol. 2024 Aug 26;15:1412513. doi: 10.3389/fimmu.2024.1412513. eCollection 2024. Front Immunol. 2024. PMID: 39253084 Free PMC article. Review. - Evolution of T cells in the cancer-resistant naked mole-rat.
Lin TD, Rubinstein ND, Fong NL, Smith M, Craft W, Martin-McNulty B, Perry R, Delaney MA, Roy MA, Buffenstein R. Lin TD, et al. Nat Commun. 2024 Apr 11;15(1):3145. doi: 10.1038/s41467-024-47264-x. Nat Commun. 2024. PMID: 38605005 Free PMC article. - CD3 downregulation identifies high-avidity human CD8 T cells.
Clutton GT, Weideman AMK, Mischell MA, Kallon S, Conrad SZ, Shaw FR, Warren JA, Lin L, Kuruc JD, Xu Y, Gay CM, Armistead PM, G Hudgens M, Goonetilleke NP. Clutton GT, et al. Clin Exp Immunol. 2024 Feb 19;215(3):279-290. doi: 10.1093/cei/uxad124. Clin Exp Immunol. 2024. PMID: 37950348 Free PMC article. - Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID-19 survivors.
Jia C, Zhou Z, Pan W, Zhang P, Yang M, Zhao M, Li B, Liu P, Zhang Q, Kong X, Li K, Yue T, Cai T, Wang Z, De Clercq E, Li S, Li G, Liu J, Wu H, Lu Q. Jia C, et al. J Med Virol. 2023 Jan;95(1):e28340. doi: 10.1002/jmv.28340. J Med Virol. 2023. PMID: 36420584 Free PMC article. - Boosting the Immune Response-Combining Local and Immune Therapy for Prostate Cancer Treatment.
Karwacki J, Kiełbik A, Szlasa W, Sauer N, Kowalczyk K, Krajewski W, Saczko J, Kulbacka J, Szydełko T, Małkiewicz B. Karwacki J, et al. Cells. 2022 Sep 7;11(18):2793. doi: 10.3390/cells11182793. Cells. 2022. PMID: 36139368 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials